"Glycoprotein involvement in cardiac fibrobiast-myocyte communication "
“糖蛋白参与心脏成纤维细胞-肌细胞通讯”
基本信息
- 批准号:8183670
- 负责人:
- 金额:$ 32.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acute myocardial infarctionAmino AcidsAngioplastyApoptosisArchitectureBiological MarkersBlood CirculationBlood flowCardiacCardiac MyocytesCardiovascular DiseasesCell CommunicationCell DeathCell surfaceCellsCessation of lifeCicatrixClinicalCoculture TechniquesCommunicationComplementComplexCoronary arteryDetectionDevelopmentDiagnosisEnsureEnvironmentExtracellular MatrixFarGoFibroblastsGlycoconjugatesGlycoproteinsGoldHeartHeart failureHydrogen PeroxideHypoxiaImmunohistochemistryInfarctionInjuryInstructionIschemiaKnowledgeLabelLeadLinkMass Spectrum AnalysisMethodsMonitorMuscleMuscle CellsMyocardialMyocardial InfarctionMyocardial IschemiaMyocardiumMyofibroblastNecrosisOligosaccharidesOxidative StressPatientsPeptidesPhenotypePlayPolysaccharidesPredispositionPrincipal InvestigatorProteinsProteomeProteomicsReactionRegulationRelative (related person)Reperfusion TherapyRiskRoleSamplingSerumSignal TransductionSiteSliceSpecificityStressTechnologyTherapeutic InterventionTissuesTranslatingTroponinValidationVentricular RemodelingWound Healingautocrinebasecell typeclinical Diagnosisclinically relevantglycosylationin vivoinjuredinnovationmultiple reaction monitoringnovelparacrineresponseresponse to injury
项目摘要
The blockage of coronary arteries can result in a heart attack (acute myocardial infarction; Ml) and
permanent loss of cardiac muscle tissue. The resulting destruction of the complex cardiac architecture,
formation of scar tissue, and myocardial remodeling increases risk of death. The heart's initial response to
injury is synchronous and involves, in part, the reciprocal interaction between cardiac fibroblasts and
myocytes, the two primary cell types comprising the heart. Recent findings suggest that soluble proteins
secreted from cardiac fibroblasts and myocytes, also called the secretome, can modulate the infarct
microenvironment (extracellular matrix, ECM). It is the cell surface that not only acts as a physical barrier
but senses of the local ECM microenvironment that initiates the intrinsic cellular protective mechanisms upon
injury. Thus, the cell-environment interface is the main site of this interplay. We hypothesize that
fibroblasts are the linchpin and their respond to injury launches wound healing while also promoting myocyte
survival. Fibroblasts accomplish this by altering the ECM microenvironment surrounding myocytes,
especially those present in the infarct border zone. Many of the proteins comprising cell-environment
interface are glycosylated. In this proposal, we will use a number of innovative methods to target, enrich,
quantify (relative and absolute) and characterize the glycoproteome of the cell-environment interface of
myocytes and fibroblasts alone and in co-culture with and without injury induced by H2O2. This includes using
a novel twist when co-culturing, in which the proteins from one cell type have a covalent quantitative labeled
which provides a mass spectrometry friendly marker to distinguishing the cell origin of each protein. We
hypothesize that cell-specific glycoproteome comprising the cell-environment interface is responsible to the
intrinsic susceptibility to H2O2 of myocytes compared to fibroblasts (SA 1). Furthermore, that a subset of the
fibroblast-specific secreted proteins which are elevated in co-culture induces myocyte-protection and this
protective phenotype is enhanced by the action of when fibroblast, themselves are injured (SA-2). Finally,
we hypothesize that glycoproteins present in the microenvironment which are exclusively elevated in
response of H2O2 will be detected in the circulation of patients with myocardial injury (ischemia) prior to the
elevation of cardiac troponins (gold standard markers for Ml). In summary, the protein complement of the
cell-environment interface has not been fully elucidated for either cardiac fibroblasts or myocytes. This
knowledge is fundamental to developing clinical approaches to protect the heart and potentially provide
robust clinical biomarkers
RELEVANCE (See instructions);
This is the first systematic analysis of the glycoproteins which comprise the secretome and cell surface of
myocytes and fibroblast, two major cell types of the heart, for which their interaction is synergetic and can
results in myocyte protection. These protective glycoproteins could be targets suitable for therapeutic
intervention. As well, the myocardial and cardiac fibroblast specific hypoxic stimulated secreted proteins
from cardiac fibroblasts and myocytes that circulating and are elevated in patients with myocardial ischemia
冠状动脉阻塞可导致心脏病发作(急性心肌梗死;毫升)
心肌组织的永久性丢失。结果是复杂的心脏结构遭到破坏,
疤痕组织的形成和心肌重塑增加了死亡的风险。心脏的初始反应
损伤是同步的,部分涉及心脏成纤维细胞和心脏细胞之间的相互作用。
心肌细胞,构成心脏的两种主要细胞类型。最近的发现表明,可溶性蛋白质
心脏成纤维细胞和心肌细胞分泌的物质,也称为分泌体,可以调节心肌梗死
微环境(细胞外基质)。细胞表面不仅是一道物理屏障
但感觉到局部细胞外基质微环境启动了内在的细胞保护机制
受伤。因此,细胞-环境界面是这种相互作用的主要场所。我们假设
成纤维细胞是关键,它们对损伤的反应启动了伤口的愈合,同时也促进了心肌细胞
生死存亡。成纤维细胞通过改变肌细胞周围的细胞外基质微环境来实现这一点,
尤其是那些出现在梗塞边缘区域的。构成细胞环境的许多蛋白质
界面是糖基化的。在这项建议中,我们将运用多项创新方法,有针对性地、丰富
定量(相对和绝对)和表征细胞-环境界面的糖蛋白质组
心肌细胞和成纤维细胞单独和在有或没有过氧化氢损伤的情况下共同培养。这包括使用
共培养时的一种新的扭曲,其中来自一种细胞类型的蛋白质具有共价定量标记
这为区分每个蛋白质的细胞来源提供了一个质谱学友好的标记。我们
假设组成细胞-环境界面的细胞特异性糖蛋白组负责
与成纤维细胞相比,心肌细胞对H_2O_2的内在敏感性(SA_1)。此外,它的一个子集
在共培养中升高的成纤维细胞特异性分泌蛋白诱导心肌细胞保护,这
当成纤维细胞自身受到损伤时,保护性表型会增强(SA-2)。最后,
我们假设糖蛋白存在于微环境中,它只在
心肌损伤(缺血)患者的循环中将检测到过氧化氢的反应
心肌肌钙蛋白升高(毫升的金标准标记物)。综上所述,补体的蛋白质
心脏成纤维细胞和心肌细胞的细胞-环境界面尚未完全阐明。这
知识是开发临床方法以保护心脏并潜在地提供
强健的临床生物标志物
相关性(见说明);
这是第一次系统分析组成黄瓜分泌体和细胞表面的糖蛋白。
肌细胞和成纤维细胞是心脏的两种主要细胞类型,它们之间的相互作用是协同的,可以
对心肌细胞有保护作用。这些保护性糖蛋白可能是适合治疗的靶点。
干预。此外,心肌和心脏成纤维细胞特异性低氧刺激的分泌蛋白
来自心肌缺血患者循环和升高的心脏成纤维细胞和肌细胞
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer E Van Eyk其他文献
Transgenic Model of Myofilament Dysfunction in Myocardial Stunning
心肌顿抑中心肌肌丝功能障碍的转基因模型
- DOI:
10.1203/00006450-199904020-00171 - 发表时间:
1999-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Anne M Murphy;Dimitrios Georgakopoulos;David A Kass;Jennifer E Van Eyk;Eduardo Marban - 通讯作者:
Eduardo Marban
Jennifer E Van Eyk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer E Van Eyk', 18)}}的其他基金
CORALE-SeroNet Immune Bioanalytics Core
CORALE-SeroNet 免疫生物分析核心
- 批准号:
10688398 - 财政年份:2020
- 资助金额:
$ 32.8万 - 项目类别:
CORALE-SeroNet Immune Bioanalytics Core
CORALE-SeroNet 免疫生物分析核心
- 批准号:
10222435 - 财政年份:2020
- 资助金额:
$ 32.8万 - 项目类别:
A new post-translational modification, citrullination, changes in heart failure
一种新的翻译后修饰,瓜氨酸化,心力衰竭的变化
- 批准号:
8256288 - 财政年份:2012
- 资助金额:
$ 32.8万 - 项目类别:
A new post-translational modification, citrullination, changes in heart failure
一种新的翻译后修饰,瓜氨酸化,心力衰竭的变化
- 批准号:
8431700 - 财政年份:2012
- 资助金额:
$ 32.8万 - 项目类别:
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
塔斯马尼亚州::75 0872::塔斯马尼亚州约翰霍普金斯大学心力衰竭蛋白质组学创新中心
- 批准号:
8320842 - 财政年份:2010
- 资助金额:
$ 32.8万 - 项目类别:
CRT and Mitochondrial Function and Proteome Post-Translational Modifications
CRT 与线粒体功能和蛋白质组翻译后修饰
- 批准号:
8011127 - 财政年份:2010
- 资助金额:
$ 32.8万 - 项目类别:
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
塔斯马尼亚州::75 0872::塔斯马尼亚州约翰霍普金斯大学心力衰竭蛋白质组学创新中心
- 批准号:
8537322 - 财政年份:2010
- 资助金额:
$ 32.8万 - 项目类别:
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
塔斯马尼亚州::75 0872::塔斯马尼亚州约翰霍普金斯大学心力衰竭蛋白质组学创新中心
- 批准号:
8175610 - 财政年份:2010
- 资助金额:
$ 32.8万 - 项目类别:
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
塔斯马尼亚州::75 0872::塔斯马尼亚州约翰霍普金斯大学心力衰竭蛋白质组学创新中心
- 批准号:
8727408 - 财政年份:2010
- 资助金额:
$ 32.8万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 32.8万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 32.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别: